Angiotensin IV reverses the acute cerebral blood flow reduction after experimental subarachnoid hemorrhage in the rat

J Cereb Blood Flow Metab. 1994 Nov;14(6):1096-9. doi: 10.1038/jcbfm.1994.143.

Abstract

The effect of angiotensin (ANG) IV on CBF after experimental subarachnoid hemorrhage (SAH) was studied in rats using laser-Doppler flowmetry. ANG IV (1 microgram/kg/min i.v.) or saline treatments were started 20 min after SAH. ANG IV increased CBF (from 45 to 84% of baseline) by 60 min. In the saline group, CBF remained low (51%). Pretreatment with the specific ANG II antagonist Sar1, Ile8-ANG II did not antagonize ANG IV. Determination of nitric oxide synthase (NOS) activity in vitro or inhibition of NOS in vivo did not support a role for NO in the action of ANG IV.

MeSH terms

  • Amino Acid Oxidoreductases / metabolism
  • Angiotensin II / analogs & derivatives*
  • Angiotensin II / antagonists & inhibitors
  • Angiotensin II / pharmacology
  • Animals
  • Arginine / analogs & derivatives
  • Arginine / pharmacology
  • Blood Pressure / drug effects
  • Cerebral Arteries / enzymology
  • Cerebrovascular Circulation / drug effects*
  • Male
  • NG-Nitroarginine Methyl Ester
  • Nitric Oxide / antagonists & inhibitors
  • Nitric Oxide Synthase
  • Rats
  • Rats, Sprague-Dawley
  • Subarachnoid Hemorrhage / physiopathology*
  • Time Factors

Substances

  • Angiotensin II
  • angiotensin II, des-Asp(1)-des-Arg(2)-Ile(5)-
  • Nitric Oxide
  • Arginine
  • Nitric Oxide Synthase
  • Amino Acid Oxidoreductases
  • NG-Nitroarginine Methyl Ester